Cadila Pharmaceuticals launches lung cancer drug Economic Times As per the company's statement, Mycidac-C is an innovative research product for the patients suffering from Non Small Cell Lung Cancer (NSCLC). The drug has been approved for launch in India by the Drug Controller General of India (DCGI). It targets ... |
